Breaking News Instant updates and real-time market news.

2023-03-29 08:49:38 ABT Abbott $97.10 / -1.345 (-1.37%) 08:49 03/29/23 03/29 08:49 03/29/23 08:49	Abbott assumed with a Buy at UBS UBS analyst Danielle Antalffy assumed coverage of Abbott with a Buy rating and $117 price target as part of a sector note on U.S. Medical Supplies and Devices. UBS believes Abbott's ability to sustain above-market Medical Devices growth and top-tier high-single-digit total company sales growth is underappreciated, and sees Abbott's recent and upcoming product launches as offering a plethora of shots on goal to sustain its recent positive momentum within Medical Devices, the analyst tells investors in a research note.	28 Apr

2023-03-29 08:49:38

ABT

Abbott

$97.10 / -1.345 (-1.37%)

08:49

03/29/23

03/29

08:49

03/29/23

08:49

Abbott assumed with a Buy at UBS

UBS analyst Danielle Antalffy assumed coverage of Abbott with a Buy rating and $117 price target as part of a sector note on U.S. Medical Supplies and Devices. UBS believes Abbott's ability to sustain above-market Medical Devices growth and top-tier high-single-digit total company sales growth is underappreciated, and sees Abbott's recent and upcoming product launches as offering a plethora of shots on goal to sustain its recent positive momentum within Medical Devices, the analyst tells investors in a research note.

28
Apr

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Lantheus selloff on competitor approval overdone, says Mizuho » 06:42 05/30/23 05/30 06:42 05/30/23 06:42 LNTH Lantheus $91.06 / -6.855 (-7.00%) Mizuho views… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:42 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/23/23 Lantheus announces payment to CVR holders of $1.15 per CVR 04/24/23 Lantheus, Point Biopharma announces FDA grants FTD for 177Lu-PNT2002 03/17/23 Lantheus appoints Paul Blanchfield as president, Dan Niedzwiecki as CAO 02/16/23 Lantheus presents data on piflufolastat F 18 at 2023 ASCO symposium LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/05/23 SVB Securities Lantheus price target raised to $127 from $120 at SVB Securities 05/05/23 Truist Lantheus price target raised to $125 from $115 at Truist 05/05/23 JMP Securities Lantheus price target raised to $130 from $120 at JMP Securities 05/05/23 Mizuho Lantheus price target raised to $125 from $115 at Mizuho LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/04/23 Lantheus sees 2023 adjusted EPS $5.45-$5.70, consensus $4.95 05/04/23 Lantheus sees Q2 adjusted EPS $1.25-$1.33, consensus $1.21 05/04/23 Lantheus reports Q1 adjusted EPS $1.47, consensus $1.26 02/23/23 Lantheus sees FY23 adjusted EPS $4.95 - $5.10, consensus $4.21 LNTH Lantheus $91.06 / -6.855 (-7.00%) 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning
Recommendations	Omega Healthcare price target lowered to $31 from $32 at Mizuho » 06:39 05/30/23 05/30 06:39 05/30/23 06:39 OHI Omega Healthcare $28.34 / +0.25 (+0.89%) Mizuho analyst Vikram… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 01/24/23 Omega Healthcare trading resumes 01/24/23 Omega Healthcare trading halted, volatility trading pause 01/09/23 Omega Healthcare sees EBITDA declining in Q1 vs. Q4 OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 05/03/23 Stifel Omega Healthcare price target lowered to $33 from $36 at Stifel 04/19/23 Wells Fargo Omega Healthcare initiated with an Overweight at Wells Fargo 01/13/23 Baird Omega Healthcare price target lowered to $29 from $32 at Baird 01/09/23 Credit Suisse Omega Healthcare downgraded to Underperform from Neutral at Credit Suisse OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 05/02/23 Omega Healthcare reports Q1 adjusted FFO 66c, consensus 60c 02/02/23 Omega Healthcare reports Q4 adjusted FFO 73c, consensus 73c 06/05/23 Omega Healthcare Investors
Recommendations	Ventas price target lowered to $53 from $60 at Mizuho » 06:39 05/30/23 05/30 06:39 05/30/23 06:39 VTR Ventas $42.87 / +0.045 (+0.11%) Mizuho analyst Vikram… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VTR Ventas $42.87 / +0.045 (+0.11%) 04/24/23 Land & Buildings letter to Ventas notes significant NOI underperformance 01/23/23 Ventas names J. Justin Hutchens to additional role of chief investment officer VTR Ventas $42.87 / +0.045 (+0.11%) 04/25/23 Barclays Ventas price target lowered to $55 from $57 at Barclays 04/19/23 Wells Fargo Wells Fargo starts Ventas with Overweight on senior housing growth 04/19/23 Wells Fargo Ventas initiated with an Overweight at Wells Fargo 04/12/23 Credit Suisse Ventas price target lowered to $50 from $51 at Credit Suisse VTR Ventas $42.87 / +0.045 (+0.11%) 05/08/23 Ventas backs FY23 normalized FFO view $2.90-$3.04, consensus $2.96 05/08/23 Ventas reports Q1 normalized FFO 74c, consensus 70c 02/09/23 Ventas sees FY23 normalized FFO $2.90-$3.04, consensus $3.07 02/09/23 Ventas reports Q4 normalized FFO 73c, consensus 72c
Recommendations	Welltower price target lowered to $86 from $91 at Mizuho » 06:38 05/30/23 05/30 06:38 05/30/23 06:38 WELL Welltower $73.54 / -0.07 (-0.10%) Mizuho lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:38 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WELL Welltower $73.54 / -0.07 (-0.10%) 05/08/23 Brookdale Senior Living enters revised agreements with Welltower 05/02/23 Welltower reports SS NOI growth of 23.4% year-over-year in quarter 04/24/23 Land & Buildings letter to Ventas notes significant NOI underperformance 02/15/23 Welltower, Retirement Unlimited announce partnership WELL Welltower $73.54 / -0.07 (-0.10%) 05/24/23 Deutsche Bank Deutsche ups target on 'must-own' Welltower to $84 from $81 05/16/23 RBC Capital Welltower price target raised to $87 from $82 at RBC Capital 04/19/23 Wells Fargo Wells Fargo starts Ventas with Overweight on senior housing growth 04/19/23 Wells Fargo Welltower initiated with an Overweight at Wells Fargo WELL Welltower $73.54 / -0.07 (-0.10%) 05/03/23 Welltower reports Q1 normalized FFO 85c, consensus 82c 05/02/23 Welltower raises normalized FFO view to $3.39-$3.54 from $3.35-$3.53 02/15/23 Welltower sees FY23 normalized FFO $3.35-$3.53, consensus $3.57 02/15/23 Welltower reports Q4 normalized FFO 83c, consensus 82c WELL Welltower $73.54 / -0.07 (-0.10%) 12/07/22 Welltower 'obfuscating its distressed assets,' Hindenburg says in short report 12/07/22 Welltower short report published by Hindenburg Research WELL Welltower $73.54 / -0.07 (-0.10%) 04/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/23 Fly Intel: After-Hours Movers 02/03/23 Sell these stocks now, proven algorithm says 12/07/22 What You Missed On Wall Street On Wednesday WELL Welltower $73.54 / -0.07 (-0.10%) 04/06/23 Early notable gainers among liquid option names on April 6th
Recommendations	Xcel Energy price target lowered to $69 from $72 at Mizuho » 06:36 05/30/23 05/30 06:36 05/30/23 06:36 XEL Xcel Energy $64.34 / +0.06 (+0.09%) Mizuho analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:36 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options XEL Xcel Energy $64.34 / +0.06 (+0.09%) 02/22/23 Xcel Energy raises quarterly dividend by 6.7% to 52c per share 01/26/23 Xcel Energy, Form Energy team to deploy iron-air battery systems XEL Xcel Energy $64.34 / +0.06 (+0.09%) 04/05/23 BMO Capital Xcel Energy price target lowered to $73 from $74 at BMO Capital 03/17/23 Mizuho Xcel Energy price target lowered to $72 from $75 at Mizuho 12/14/22 Wells Fargo Xcel Energy price target raised to $76 from $69 at Wells Fargo 11/21/22 Credit Suisse Xcel Energy downgraded to Neutral from Outperform at Credit Suisse XEL Xcel Energy $64.34 / +0.06 (+0.09%) 05/19/23 Xcel Energy backs FY23 EPS guidance of $3.30-$3.40, consensus $3.38 04/27/23 Xcel Energy backs FY23 EPS view $3.30-$3.40, consensus $3.38 04/27/23 Xcel Energy reports Q1 EPS 76c, consensus 74c 04/05/23 Xcel Energy affirms FY23 EPS $3.30-$3.40, updates on MN rate case XEL Xcel Energy $64.34 / +0.06 (+0.09%) 03/24/23 Early notable gainers among liquid option names on March 24th 03/15/23 Early notable gainers among liquid option names on March 15th
Recommendations	C4 Therapeutics price target lowered to $10, transferred at Evercore ISI » 06:35 05/30/23 05/30 06:35 05/30/23 06:35 CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:35 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 05/04/23 C4 Therapeutics announces key upcoming milestones 02/28/23 Tango Therapeutics appoints Crystal as President of Research, Development 02/23/23 C4 Therapeutics announces upcoming milestones 01/30/23 C4 Therapeutics announces first patient dosed in Phase 1/2 trial of CFT1946 CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 05/08/23 H.C. Wainwright C4 Therapeutics price target lowered to $25 from $35 at H.C. Wainwright 03/28/23 BofA C4 Therapeutics price target lowered to $5 from $11 at BofA 02/24/23 Credit Suisse Credit Suisse ups C4 Therapeutics to Neutral on 'dramatically' improved outlook 02/24/23 Credit Suisse C4 Therapeutics upgraded to Neutral from Underperform at Credit Suisse CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 05/04/23 C4 Therapeutics reports Q1 EPS (71c), consensus (75c) 02/23/23 C4 Therapeutics reports 2022 EPS ($2.62), consensus ($2.57) CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 02/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/23 C4 Therapeutics, Inc.
Recommendations	Salesforce price target raised to $250 from $225 at Wells Fargo » 06:33 05/30/23 05/30 06:33 05/30/23 06:33 CRM Salesforce $215.46 / +5.58 (+2.66%) Wells Fargo raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CRM Salesforce $215.46 / +5.58 (+2.66%) 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/15/23 Appaloosa takes stake in FedEx, exits Aptiv 05/15/23 Lone Pine boosts Salesforce stake, reduces Visa, Mastercard stakes 05/15/23 Starboard takes stake in Rogers Corp, boosts stake in Splunk CRM Salesforce $215.46 / +5.58 (+2.66%) 06:13 Today Canaccord Salesforce price target raised to $230 from $215 at Canaccord 05/26/23 Evercore ISI Workday price target raised to $240 from $225 at Evercore ISI 05/26/23 Citi Salesforce price target raised to $229 from $210 at Citi 05/25/23 Wedbush Salesforce price target raised to $230 from $220 at Wedbush CRM Salesforce $215.46 / +5.58 (+2.66%) 03/01/23 Salesforce guides initial FY24 EPS $7.12-7.14, consensus $5.84 03/01/23 Salesforce sees Q1 EPS $1.60-$1.61, consensus $1.32 03/01/23 Salesforce reports Q4 EPS $1.68, consensus $1.36 03/01/23 Notable companies reporting after market close CRM Salesforce $215.46 / +5.58 (+2.66%) 05/26/23 Shopify nominates Bret Taylor for board seat, The Information says 05/16/23 Tech companies resumed hiring foreign workers this week, Lee Fang reports 04/24/23 Microsoft would stop bundling Teams, Office to avoid formal EU probe, FT says 03/24/23 Salesforce considering further job cuts, COO tells Bloomberg CRM Salesforce $215.46 / +5.58 (+2.66%) 04/24/23 What Wall Street is saying about Microsoft ahead of earnings 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/24/23 What You Missed On Wall Street This Morning 05/31/23 Software Conference 05/31/23 Salesforce - CRM 06/08/23 Salesforce Inc CRM Salesforce $215.46 / +5.58 (+2.66%) 03/03/23 Unusually active option classes on open March 3rd 03/02/23 Early notable gainers among liquid option names on March 2nd 03/01/23 Salesforce options imply 6.7% move in share price post-earnings 01/27/23 Salesforce call buyer realizes 114% same-day gains
Upgrade	BofA upgrades ChargePoint to Buy with shares at all-time lows » 06:33 05/30/23 05/30 06:33 05/30/23 06:33 CHPT ChargePoint $8.50 / +0.175 (+2.10%) BofA analyst Alex Vrabel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CHPT ChargePoint $8.50 / +0.175 (+2.10%) 04/04/23 ChargePoint enters international agreement with ALD Automotive 03/03/23 ChargePoint falls -7.9% 03/03/23 ChargePoint falls -9.2% 02/23/23 Fisker names ChargePoint as North America partner for EV charging stations CHPT ChargePoint $8.50 / +0.175 (+2.10%) 06:05 Today BofA ChargePoint upgraded to Buy from Neutral at BofA 05/08/23 B. Riley ChargePoint price target lowered to $12 from $18 at B. Riley 05/02/23 Guggenheim ChargePoint initiated with a Neutral at Guggenheim 04/25/23 Stifel Wallbox price target lowered to $9 from $14 at Stifel CHPT ChargePoint $8.50 / +0.175 (+2.10%) 03/03/23 ChargePoint sees Q1 revenue $122M-$132M, consensus $152.5M 03/02/23 ChargePoint reports Q4 EPS (23c), consensus (17c) 12/01/22 ChargePoint narrows FY23 revenue view to $475M-$485M from $450M-$500M 12/01/22 ChargePoint sees Q4 revenue $160M-$170M, consensus $160.91M CHPT ChargePoint $8.50 / +0.175 (+2.10%) 02/10/23 DOT's coming EV charger rules may pressure Tesla to open network, Reuters says CHPT ChargePoint $8.50 / +0.175 (+2.10%) 05/08/23 What You Missed This Week in EVs and Clean Energy 05/02/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/27/23 What You Missed This Week in EVs and Clean Energy 03/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/23 ChargePoint - CHPT 07/18/23 ChargePoint Holdings Inc CHPT ChargePoint $8.50 / +0.175 (+2.10%) 05/26/23 ChargePoint Holdings put volume heavy and directionally bearish 05/18/23 ChargePoint Holdings put volume heavy and directionally bearish 05/10/23 Largest borrow rate increases among liquid names 05/05/23 Largest borrow rate increases among liquid names
Earnings	Skyline Champion reports Q4 EPS $1.00, consensus 93c » 06:32 05/30/23 05/30 06:32 05/30/23 06:32 SKY Skyline Champion $64.49 / +0.435 (+0.68%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:32 Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events SKY Skyline Champion $64.49 / +0.435 (+0.68%) 02/08/23 Craig-Hallum Skyline Champion price target raised to $78 from $65 at Craig-Hallum 02/08/23 RBC Capital Skyline Champion price target raised to $65 from $54 at RBC Capital 12/30/22 Wedbush Wedbush favors four homebuilding stocks heading into 2023 12/14/22 Barclays Skyline Champion downgraded to Equal Weight from Overweight at Barclays SKY Skyline Champion $64.49 / +0.435 (+0.68%) 02/06/23 Skyline Champion reports Q3 EPS $1.44, consensus 92c SKY Skyline Champion $64.49 / +0.435 (+0.68%) 02/06/23 Fly Intel: After-Hours Movers 05/31/23 20th Annual Institutional Investor Conference 09:00 Today Skyline Champion - SKY
Hot Stocks	SpringsWorks Therapeutics says Phase 2 nirogacestat trial fully enrolled » 06:31 05/30/23 05/30 06:31 05/30/23 06:31 SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) SpringWorks Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:31 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 04/17/23 MapKure, SpringWorks, BeiGene present data from Phase 1a/1b study of BGB-3245 02/27/23 SpringsWorks announces FDA acceptance, priority review of nirogacestat NDA 12/27/22 SpringsWorks Therapeutics completes submission of nirogacestat NDA to FDA SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 04/28/23 Barclays SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays 03/07/23 H.C. Wainwright SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright 01/02/23 Barclays Barclays views GSK acquisition interest as positive for oncology stocks 12/01/22 BofA SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 05/03/23 SpringsWorks Therapeutics reports Q1 EPS ($1.18), consensus ($1.25) 02/28/23 SpringsWorks Therapeutics reports Q4 EPS ($1.19), consensus ($1.22) SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 04/22/23 Short Report: Bears pare exposure in crypto stocks as bitcoin slumps 06/02/23 Biotechnology--Pre-ASCO Reception 00:00 Today 4th Annual Oncology Innovation Summit: Insights for ASCO & EHA 08/27/23 PDUFA Date for Nirogacestat

Recommendations	ServiceNow price target raised to $665 from $586 at Bernstein » 06:30 05/30/23 05/30 06:30 05/30/23 06:30 NOW ServiceNow $537.41 / +5.65 (+1.06%) Bernstein analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:30 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/18/23 Wipro enters into five-year business partnership with ServiceNow 05/18/23 Juniper, ServiceNow team to deliver end-to-end automation for networks 05/17/23 ServiceNow, Nvidia announce partnership 05/17/23 ServiceNow announces multiyear North American partnership with NHL NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/26/23 Evercore ISI Workday price target raised to $240 from $225 at Evercore ISI 05/18/23 Barclays ServiceNow price target raised to $559 from $551 at Barclays 05/17/23 Goldman Sachs Goldman Sachs increasingly positive on ServiceNow after Analyst Day 05/17/23 Piper Sandler Piper says 'don't split hairs,' buy ServiceNow shares NOW ServiceNow $537.41 / +5.65 (+1.06%) 04/26/23 ServiceNow reports Q1 adjusted EPS $2.37, consensus $2.04 04/26/23 Notable companies reporting after market close 01/25/23 ServiceNow reports Q4 EPS 2.28, consensus $2.02 01/25/23 Notable companies reporting after market close NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/17/23 What You Missed On Wall Street On Wednesday 05/17/23 What You Missed On Wall Street This Morning 04/04/23 What You Missed On Wall Street On Tuesday 04/04/23 What You Missed On Wall Street This Morning 05/31/23 Software Conference 06/01/23 ServiceNow, Inc. NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/17/23 Unusually active option classes on open May 17th 05/10/23 Early notable gainers among liquid option names on May 10th 04/26/23 ServiceNow options imply 5.6% move in share price post-earnings 04/04/23 Early notable gainers among liquid option names on April 4th
Upgrade	SVB upgrades Elevation Oncology to Outperform on Claudin18.2 ADC SYSA180 data » 06:27 05/30/23 05/30 06:27 05/30/23 06:27 ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:27 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) 04/17/23 Elevation Oncology presents EO-3021 preclinical PoC data 01/06/23 Elevation Oncology realigns resources, CEO resigns, cuts workforce by 30% ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) 06:04 Today SVB Securities Elevation Oncology upgraded to Outperform from Market Perform at SVB Securities 11/10/22 JPMorgan Elevation downgraded to Underweight on more difficult path at JPMorgan 11/10/22 JPMorgan Elevation Oncology downgraded to Underweight from Neutral at JPMorgan 11/07/22 SVB Securities Elevation Oncology downgraded to Market Perform from Outperform at SVB Securities ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) 05/15/23 Elevation Oncology reports Q1 EPS (72c), consensus (59c) 03/09/23 Elevation Oncology reports Q4 EPS (82c0, consensus (78c) 06/02/23 2023 ASCO Annual Meeting
Upgrade	Canadian Western Bank upgraded to Outperform from Sector Perform at RBC Capital » 06:26 05/30/23 05/30 06:26 05/30/23 06:26 CBWBF Canadian Western Bank $16.94 / -1.01 (-5.63%) RBC Capital analyst Darko… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:26 Get Free Trial ShowHide Related Items >><< Street Research CBWBF Canadian Western Bank $16.94 / -1.01 (-5.63%) 05:26 Today Barclays Canadian Western Bank price target lowered to C$26 from C$27 at Barclays 05/16/23 CIBC Canadian Western Bank price target lowered to C$28 from C$30 at CIBC 05/09/23 Barclays Canadian Western Bank price target lowered to C$27 from C$29 at Barclays 03/03/23 TD Securities Canadian Western Bank price target lowered to C$33 from C$34 at TD Securities
Initiation	Viridian Therapeutics initiated with an Outperform at RBC Capital » 06:25 05/30/23 05/30 06:25 05/30/23 06:25 VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:25 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 05/08/23 Viridian Therapeutics partners with Enable Injections 04/12/23 Viridian Therapeutics CEO buys $101K in common stock 04/12/23 Viridian Therapeutics appoints Casciano as Chief Commercial officer 02/06/23 Viridian Therapeutics appoints Scott Myers as President, CEO VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 05/10/23 Oppenheimer Viridian Therapeutics price target lowered to $40 from $45 at Oppenheimer 05/10/23 JMP Securities Viridian Therapeutics price target lowered to $44 from $46 at JMP Securities 04/17/23 Wells Fargo Viridian Therapeutics initiated with an Overweight at Wells Fargo 03/29/23 Stifel Viridian Therapeutics initiated with a Buy at Stifel VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 05/09/23 Viridian Therapeutics reports Q1 EPS ($1.61), consensus ($1.02) 03/08/23 Viridian Therapeutics reports Q4 EPS ($1.13), consensus (73c) 17 Aug VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Kenvue initiated with an Outperform at RBC Capital » 06:24 05/30/23 05/30 06:24 05/30/23 06:24 KVUE Kenvue $26.29 / -0.01 (-0.04%) , JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) RBC Capital initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:24 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 04/30/23 Fly Intel: Top five weekend stock stories JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05/25/23 Legend: Type II variation application submitted to EMA for CARVYKTI 05/25/23 Bristol-Myers granted FDA Fast Track Designation for 3 milvexian indications 05/12/23 Protagonist and Janssen report data from preclinical studies of JNJ-2113 05/11/23 Johnson & Johnson reports 61.91% increase in ownership of Nano-X Imaging KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 06:21 Today BofA Kenvue initiated with a Buy at BofA 05:13 Today Exane BNP Paribas Kenvue initiated with a Neutral at Exane BNP Paribas 05:06 Today Citi Johnson & Johnson resumed with a Buy at Citi 05:02 Today JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05:06 Today Citi Johnson & Johnson resumed with a Buy at Citi 05:02 Today JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' 04:32 Today Goldman Sachs Kenvue initiated with a Neutral at Goldman Sachs 05/24/23 Piper Sandler Cooper Companies price target raised to $430 from $375 at Piper Sandler JNJ JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 04/18/23 Johnson & Johnson raises FY23 adjusted EPS to $10.60-$10.70 from $10.45-$10.65 04/18/23 Johnson & Johnson reports Q1 adjusted EPS $2.68, consensus $2.51 04/17/23 Notable companies reporting before tomorrow's open 02/28/23 Fate Therapeutics reports Q4 EPS (58c), consensus (86c) 04 May KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says 04/30/23 J&J's Kenvue spinoff a rare IPO winner in moribund market, Barron's says JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports 05/10/23 New suitors showing interest in ShockWave Medical, Street Insider says 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/07/23 Opening Day: J&J's Kenvue jumps 20% in market debut JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05/07/23 Opening Day: J&J's Kenvue jumps 20% in market debut 04/28/23 What You Missed On Wall Street On Friday 04/28/23 What You Missed On Wall Street This Morning 04/18/23 What You Missed On Wall Street On Tuesday 06/09/23 Biotechnology 06/02/23 2023 ASCO Annual Meeting KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/10/23 Four new option listings on May 10th JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 04/18/23 Unusually active option classes on open April 18th 04/06/23 Unusually active option classes on open April 6th 04/05/23 Early notable gainers among liquid option names on April 5th 04/05/23 Unusually active option classes on open April 5th
Initiation	Kenvue initiated with a Buy at BofA » 06:21 05/30/23 05/30 06:21 05/30/23 06:21 KVUE Kenvue $26.29 / -0.01 (-0.04%) BofA analyst Anna Lizzul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:21 Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Options KVUE Kenvue $26.29 / -0.01 (-0.04%) 04/30/23 Fly Intel: Top five weekend stock stories KVUE Kenvue $26.29 / -0.01 (-0.04%) 05:13 Today Exane BNP Paribas Kenvue initiated with a Neutral at Exane BNP Paribas 05:06 Today Citi Johnson & Johnson resumed with a Buy at Citi 05:02 Today JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' 04:53 Today Citi Kenvue initiated with a Neutral at Citi 04 May KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says 04/30/23 J&J's Kenvue spinoff a rare IPO winner in moribund market, Barron's says KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/07/23 Opening Day: J&J's Kenvue jumps 20% in market debut KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/10/23 Four new option listings on May 10th
Initiation	Steris initiated with an Equal Weight at Morgan Stanley » 06:19 05/30/23 05/30 06:19 05/30/23 06:19 STE Steris $200.50 / -0.735 (-0.37%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:19 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options STE Steris $200.50 / -0.735 (-0.37%) 05/03/23 Steris announces new $500M share buyback program STE Steris $200.50 / -0.735 (-0.37%) 05/12/23 Piper Sandler Steris price target raised to $200 from $197 at Piper Sandler 05/12/23 KeyBanc Steris price target raised to $235 from $210 at KeyBanc 04/14/23 Piper Sandler Steris downgraded to Neutral from Overweight at Piper Sandler 02/15/23 JMP Securities Steris price target lowered to $240 from $250 at JMP Securities STE Steris $200.50 / -0.735 (-0.37%) 05/10/23 Steris sees FY24 adjusted EPS $8.55-$8.75, consensus $8.75 05/10/23 Steris reports Q4 adjusted EPS $2.30, consensus $2.15 02/08/23 Steris sees FY23 adjusted EPS $8.00-$8.10, consensus $8.43 02/08/23 Steris reports Q3 adjusted EPS $2.02, consensus $2.19 STE Steris $200.50 / -0.735 (-0.37%) 04/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/08/23 Fly Intel: After-Hours Movers 05/31/23 Steris 06/01/23 Steris STE Steris $200.50 / -0.735 (-0.37%) 05/11/23 Early notable gainers among liquid option names on May 11th 01/10/23 Early notable gainers among liquid option names on January 10th
Initiation	Cooper Companies initiated with an Equal Weight at Morgan Stanley » 06:18 05/30/23 05/30 06:18 05/30/23 06:18 COO Cooper Companies $369.30 / -2.325 (-0.63%) Morgan Stanley initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:18 Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options COO Cooper Companies $369.30 / -2.325 (-0.63%) 05/24/23 Piper Sandler Cooper Companies price target raised to $430 from $375 at Piper Sandler 05/16/23 Stifel Cooper Companies price target raised to $420 from $380 at Stifel 05/15/23 Wells Fargo Cooper Companies price target raised to $430 from $355 at Wells Fargo 04/18/23 Mizuho Cooper Companies price target raised to $400 from $390 at Mizuho COO Cooper Companies $369.30 / -2.325 (-0.63%) 03/02/23 Cooper Companies sees FY23 EPS $12.60-$12.90, consensus $12.52 03/02/23 Cooper Companies reports Q4 EPS $2.90, consensus $2.70 12/08/22 Cooper Companies sees FY23 EPS $12.30 - $12.60, consensus $13.05 12/08/22 Cooper Companies reports Q4 EPS $2.75, consensus $3.11 COO Cooper Companies $369.30 / -2.325 (-0.63%) 03/03/23 What You Missed On Wall Street This Morning 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 12/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/23 Cooper Companies - COO COO Cooper Companies $369.30 / -2.325 (-0.63%) 03/03/23 Early notable gainers among liquid option names on March 3rd
Periodicals	Tesla CEO Musk's private jet lands in Beijing, Reuters reports » 06:16 05/30/23 05/30 06:16 05/30/23 06:16 TSLA Tesla $193.14 / +8.715 (+4.73%) A private jet used by… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:16 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TSLA Tesla $193.14 / +8.715 (+4.73%) 05/25/23 Ford EV customers to gain access to 12,000 Tesla superchargers 05/25/23 Ford, Tesla CEOs to host Twitter Spaces chat on accelerating EV adoption 05/16/23 Tesla CEO says we adjust pricing to match demand based on incoming daily data 05/16/23 Tesla CEO says there's some 'good logic' to starting advertising to reach people TSLA Tesla $193.14 / +8.715 (+4.73%) 06:06 Today Barclays Tesla must address model concentration, says Barclays 05/23/23 Oppenheimer Shares may move higher near-term as Tesla outperforms peers, says Oppenheimer 05/18/23 Wedbush Wedbush says Tesla/Musk strategy feels solid as investors focus on price wars 05/17/23 Wedbush Potential advertising campaign 'a major positive' for Tesla, says Wedbush TSLA Tesla $193.14 / +8.715 (+4.73%) 04/19/23 Tesla reports Q1 EPS 85c, consensus 85c 04/19/23 Notable companies reporting after market close 03/02/23 Aehr Test Systems reiterates annual guidance, comments on Tesla statements 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 TSLA Tesla $193.14 / +8.715 (+4.73%) 05/25/23 'Huge amounts' of information allegedly leaked from Tesla, Handelsblatt says 05/23/23 DeSantis will launch his presidential bid with Elon Musk, NBC News reports 05/23/23 Tesla lists China-made Model 3, Model Y cars for sale in Canada, Reuters says 05/19/23 India minister tells Reuters Tesla 'serious' about manufacturing base plans TSLA Tesla $193.14 / +8.715 (+4.73%) 05/26/23 What You Missed On Wall Street On Friday 05/26/23 What You Missed On Wall Street This Morning 05/23/23 What You Missed On Wall Street On Tuesday 05/22/23 What You Missed This Week in EVs and Clean Energy TSLA Tesla $193.14 / +8.715 (+4.73%) 05/24/23 Notable open interest changes for May 24th 05/23/23 Notable open interest changes for May 23rd 05/23/23 Tesla call buyer realizes 64% same-day gains 05/22/23 Notable open interest changes for May 22nd
Periodicals	CEO Olczak charting path for Philip Morris to become an ESG stock, FT reports » 06:16 05/30/23 05/30 06:16 05/30/23 06:16 PM Philip Morris $90.86 / +0.09 (+0.10%) Philip Morris' CEO… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:16 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PM Philip Morris $90.86 / +0.09 (+0.10%) 04/23/23 Fly Intel: Top five weekend stock stories 03/13/23 Kaival Brands highlights official launch of VEEBA in the UK 01/29/23 Philip Morris announces agreement to extend, deepen collaboration with KT&G 01/26/23 FDA authorizes three new Marlboro heated tobacco products PM Philip Morris $90.86 / +0.09 (+0.10%) 04/13/23 Stifel Philip Morris resumed with a Buy at Stifel 03/30/23 JPMorgan Philip Morris upgraded to Overweight from Neutral at JPMorgan 03/01/23 UBS UBS upgrades Philip Morris to Buy into heated tobacco launches 03/01/23 UBS Philip Morris upgraded to Buy from Neutral at UBS PM Philip Morris $90.86 / +0.09 (+0.10%) 04/20/23 Philip Morris sees Q2 EPS $1.42-$1.47, consensus $1.60 04/20/23 Philip Morris reports Q1 EPS $1.38, consensus $1.34 04/19/23 Notable companies reporting before tomorrow's open 04/19/23 Notable companies reporting before tomorrow's open PM Philip Morris $90.86 / +0.09 (+0.10%) 04/23/23 Nvidia, others can benefit from falling dollar, Barron's says 01/25/23 Juul in deal discussions with Philip Morris, Altria, Japan Tobacco, WSJ says 01/21/23 Wells Fargo, Disney among stocks watched by value investors, Barron's says 01/07/23 Philip Morris' stock about to get 'smoking hot,' Barron's says PM Philip Morris $90.86 / +0.09 (+0.10%) 04/20/23 Fly Intel: Pre-market Movers 04/16/23 Buy/Sell: Wall Street's top 10 stock calls this week 04/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/30/23 What You Missed On Wall Street On Thursday 07/20/23 Philip Morris - PM PM Philip Morris $90.86 / +0.09 (+0.10%) 02/24/23 Philip Morris call volume above normal and directionally bullish 01/19/23 Early notable gainers among liquid option names on January 19th

Initiation	Confluent initiated with Buy on data streaming growth at Needham » 06:14 05/30/23 05/30 06:14 05/30/23 06:14 CFLT Confluent $28.69 / +0.7 (+2.50%) Needham analyst Mike… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:14 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CFLT Confluent $28.69 / +0.7 (+2.50%) 01/27/23 Confluent restructuring includes 8% workforce reduction 01/06/23 Confluent to acquire Immerok, terms undisclosed 12/13/22 Confluent appoints Shaun Clowes as chief product officer CFLT Confluent $28.69 / +0.7 (+2.50%) 06:09 Today Needham Confluent initiated with a Buy at Needham 05/05/23 Deutsche Bank Confluent price target lowered to $27 from $29 at Deutsche Bank 05/04/23 TD Cowen Confluent price target lowered to $28 from $30 at TD Cowen 05/04/23 JMP Securities Confluent price target lowered to $31 from $33 at JMP Securities CFLT Confluent $28.69 / +0.7 (+2.50%) 05/03/23 Confluent sees FY23 EPS (20c) to (14c), consensus (26c) 05/03/23 Confluent sees Q2 EPS (8c) to (6c), consensus (10c) 05/03/23 Confluent reports Q1 EPS (9c), consensus (14c) 05/03/23 Notable companies reporting after market close CFLT Confluent $28.69 / +0.7 (+2.50%) 01/26/23 Confluent Chief Revenue Officer departs, The Information reports CFLT Confluent $28.69 / +0.7 (+2.50%) 05/03/23 Fly Intel: After-Hours Movers 04/12/23 What You Missed On Wall Street On Wednesday 04/12/23 What You Missed On Wall Street This Morning 02/17/23 Sell these stocks now, proven algorithm says 06/01/23 Confluent, Inc. CFLT Confluent $28.69 / +0.7 (+2.50%) 05/03/23 Confluent options imply 10.7% move in share price post-earnings 01/30/23 Confluent options imply 9.6% move in share price post-earnings
Recommendations	Salesforce price target raised to $230 from $215 at Canaccord » 06:13 05/30/23 05/30 06:13 05/30/23 06:13 CRM Salesforce $215.46 / +5.58 (+2.66%) Canaccord analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:13 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CRM Salesforce $215.46 / +5.58 (+2.66%) 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/15/23 Appaloosa takes stake in FedEx, exits Aptiv 05/15/23 Lone Pine boosts Salesforce stake, reduces Visa, Mastercard stakes 05/15/23 Starboard takes stake in Rogers Corp, boosts stake in Splunk CRM Salesforce $215.46 / +5.58 (+2.66%) 05/26/23 Evercore ISI Workday price target raised to $240 from $225 at Evercore ISI 05/26/23 Citi Salesforce price target raised to $229 from $210 at Citi 05/25/23 Wedbush Salesforce price target raised to $230 from $220 at Wedbush 05/23/23 Jefferies Expectations 'low' for Salesforce Q1 report, says Jefferies CRM Salesforce $215.46 / +5.58 (+2.66%) 03/01/23 Salesforce guides initial FY24 EPS $7.12-7.14, consensus $5.84 03/01/23 Salesforce sees Q1 EPS $1.60-$1.61, consensus $1.32 03/01/23 Salesforce reports Q4 EPS $1.68, consensus $1.36 03/01/23 Notable companies reporting after market close CRM Salesforce $215.46 / +5.58 (+2.66%) 05/26/23 Shopify nominates Bret Taylor for board seat, The Information says 05/16/23 Tech companies resumed hiring foreign workers this week, Lee Fang reports 04/24/23 Microsoft would stop bundling Teams, Office to avoid formal EU probe, FT says 03/24/23 Salesforce considering further job cuts, COO tells Bloomberg CRM Salesforce $215.46 / +5.58 (+2.66%) 04/24/23 What Wall Street is saying about Microsoft ahead of earnings 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/24/23 What You Missed On Wall Street This Morning 05/31/23 Software Conference 05/31/23 Salesforce - CRM 06/08/23 Salesforce Inc CRM Salesforce $215.46 / +5.58 (+2.66%) 03/03/23 Unusually active option classes on open March 3rd 03/02/23 Early notable gainers among liquid option names on March 2nd 03/01/23 Salesforce options imply 6.7% move in share price post-earnings 01/27/23 Salesforce call buyer realizes 114% same-day gains
Recommendations	IAC price target raised to $72 from $65 at KeyBanc » 06:13 05/30/23 05/30 06:13 05/30/23 06:13 IAC IAC $55.51 / -0.32 (-0.57%) , ANGI Angi Inc. $3.21 / -0.04 (-1.23%) KeyBanc raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:13 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IAC ANGI IAC IAC $55.51 / -0.32 (-0.57%) 01/11/23 IAC December Angi Inc. total revenue up 6% from last year 12/11/22 Fly Intel: Top five weekend stock stories 12/08/22 IAC reports November Angi Inc. total revenue up 5% from last year ANGI Angi Inc. $3.21 / -0.04 (-1.23%) 05/23/23 TCS Capital calls on Yelp board to begin exploring strategic alternatives 05/04/23 Angi announces new partnership with SkillsUSA to sponsor National Signing Day 01/11/23 Angi Inc. reports December revenue up 6% from last year 12/08/22 IAC reports November Angi Inc. total revenue up 5% from last year IAC ANGI IAC IAC $55.51 / -0.32 (-0.57%) 05/18/23 Jefferies IAC price target raised to $80 from $70 at Jefferies 05/12/23 Citi IAC price target raised to $71 from $64 at Citi 05/12/23 Wells Fargo IAC price target raised to $79 from $70 at Wells Fargo 05/11/23 Truist IAC price target raised to $88 from $85 at Truist ANGI Angi Inc. $3.21 / -0.04 (-1.23%) 05/12/23 Wells Fargo IAC price target raised to $79 from $70 at Wells Fargo 05/11/23 Oppenheimer IAC price target raised to $75 from $70 at Oppenheimer 02/15/23 UBS IAC upgraded to Neutral from Sell at UBS 02/15/23 UBS Angi Inc. upgraded to Neutral from Sell at UBS IAC ANGI IAC IAC $55.51 / -0.32 (-0.57%) 05/09/23 IAC sees FY23 adjusted EBITDA $320M-$440M 05/09/23 IAC reports Q1 adjusted EBITDA $9.1M vs. $7.7M last year 05/09/23 Notable companies reporting after market close 02/13/23 IAC sees FY23 adjusted EBITDA $270M-$400M ANGI Angi Inc. $3.21 / -0.04 (-1.23%) 05/09/23 Angi Inc. reports Q1 adjusted EBITDA $30.5M vs. (3.2M) last year 02/13/23 Angi reports Q4 EPS (11c) , consensus (4c) 02/13/23 Notable companies reporting after market close IAC IAC IAC $55.51 / -0.32 (-0.57%) 12/10/22 Amid cheaper tech stocks, IAC may actually be cheap enough, Barron's says IAC ANGI IAC IAC $55.51 / -0.32 (-0.57%) 05/09/23 Fly Intel: After-Hours Movers 02/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/13/23 Fly Intel: After-Hours Movers 12/12/22 What You Missed On Wall Street This Morning ANGI Angi Inc. $3.21 / -0.04 (-1.23%) 02/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/13/23 Fly Intel: After-Hours Movers 12/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/31/23 51st Annual Technology, Media & Telecom Conference 06/20/23 Angi Inc 06/20/23 IAC Inc IAC IAC IAC $55.51 / -0.32 (-0.57%) 02/13/23 IAC options imply 9.1% move in share price post-earnings
Hot Stocks	Allarity reports Phase 2 results of DRP technology in breast cancer » 06:12 05/30/23 05/30 06:12 05/30/23 06:12 ALLR Allarity / + Allarity announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:12 Get Free Trial ShowHide Related Items >><< Company News Street Research ALLR Allarity / + 04/27/23 Allarity plans to accelerate Phase 2 trial for IXEMPRA 04/17/23 Allarity doses first patient in Phase 1b trial of stenoparib with dovitinib 03/28/23 Allarity provides updates to Phase 2 clinical studies of IXEMPRA and stenoparib 03/24/23 Allarity announces reverse stock split ALLR Allarity / + 08/23/22 Ladenburg Allarity downgraded to Neutral on combination strategy at Ladenburg 08/23/22 Ladenburg Allarity downgraded to Neutral from Buy at Ladenburg
Recommendations	Disney price target lowered to $105 from $121 at Truist » 06:11 05/30/23 05/30 06:11 05/30/23 06:11 DIS Disney $88.27 / +0.13 (+0.15%) Truist analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:11 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DIS Disney $88.27 / +0.13 (+0.15%) 05/29/23 Fly Intel: Top five weekend stock stories 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/15/23 Trian Fund buys GE Healthcare, exits Sysco in Q1 05/14/23 Fly Intel: Top five weekend stock stories DIS Disney $88.27 / +0.13 (+0.15%) 05/25/23 KeyBanc Disney price target lowered to $107 from $120 at KeyBanc 05/25/23 Citi ESPN+ could add $20 to Disney shares, says Citi 05/19/23 Macquarie Disney downgraded to Neutral from Outperform at Macquarie 05/12/23 JPMorgan JPMorgan lays out impacts of Disney launching EPSN streaming DIS Disney $88.27 / +0.13 (+0.15%) 05/10/23 Disney reports Q2 EPS ex-items 93c, consensus 93c 05/10/23 Notable companies reporting after market close 02/08/23 Disney reports Q1 EPS ex-items 99c, consensus 78c 02/08/23 Notable companies reporting after market close DIS Disney $88.27 / +0.13 (+0.15%) 05/25/23 Disney, Comcast fight over the future of Hulu, WSJ reports 05/23/23 Disney starts third round of planned layoffs, Deadline reports 05/22/23 Disney's income from TV networks drops faster than expected, WSJ reports 05/19/23 Disney pulls dozens of shows from Disney+, Hulu, Deadline reports DIS Disney $88.27 / +0.13 (+0.15%) 05/29/23 Box Office Battle: ‘The Little Mermaid’ wins Memorial Day weekend 05/23/23 What You Missed On Wall Street This Morning 05/22/23 What You Missed On Wall Street On Monday 05/22/23 What You Missed On Wall Street This Morning DIS Disney $88.27 / +0.13 (+0.15%) 05/12/23 Unusually active option classes on open May 12th 05/12/23 Notable open interest changes for May 12th 05/11/23 Notable open interest changes for May 11th 05/08/23 Early notable gainers among liquid option names on May 8th

Events

Earnings calls, analyst events, roadshows and more

TIGR
Today at 08:00

UP Fintech - TIGR Conference Calls
GOTU
Today at 08:00

Gaotu Techedu - GOTU Conference Calls
GLNG
Today at 08:00

Golar LNG - GLNG Conference Calls
BNR
Today at 08:00

Burning Rock Biotech - BNR Conference Calls
TCRR
Today at 08:00

TCR2 Therapeutics Inc. Firm Sponsored Meetings
MDWD
Today at 08:30

MediWound - MDWD Conference Calls
YTRA
Today at 08:30

Yatra - YTRA Conference Calls
Today at 09:00

FHFA House Price Index Y/Y: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Adjusted M/M: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Unadjusted M/M: March 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	AZTR X AZTR Azitra IPO Managers: ThinkEquity $4.50-5.50 2.4M Shares SXTP X SXTP 60 Degrees Pharmaceuticals IPO Managers: WallachBeth $4.30-6.30 1.415M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Abbott assumed with a Buy at UBS

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access